Palisade Asset Management’s Labcorp LH Stock Holding History

Palisade Asset Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29	Closed	-$8.32K	–	455
2025 Q3	$8.32K	Buy	+29	New	+$7.77K	﹤0.01%	393

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Palisade Asset Management's LH Position: Q4 2025 in Review

Palisade Asset Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 29 shares — an estimated $8.32K sold.

Palisade Asset Management first reported a position in LH in Q3 2025 and held it in 1 quarter. The position peaked at $8.32K in Q3 2025. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Palisade Asset Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Palisade Asset Management sold 29 Labcorp shares in Q4 2025, an estimated $8.32K.
Palisade Asset Management first reported a position in Labcorp in Q3 2025 and held it in 1 quarter.
Palisade Asset Management's Labcorp position peaked at $8.32K in Q3 2025.
1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.